Clinical Implications
- It did not differ significantly in children receiving Long Acting Beta Agonists (LABAs) plus Inhaled Corticosteroid) ICS vs children receiving higher doses of ICS.
- Compared with children receiving higher ICS doses, those receiving LABAs plus ICS had significantly higher PEF, less use of rescue medication, and greater short-term growth. Adverse events were not significantly different between the groups.
http://www.medscape.org/viewarticle/770166?src=cmemp
Tidak ada komentar:
Posting Komentar